Stock Movers

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- SSAB shares rise after the US and Canada failed to agree on a tariff deal, which analysts say leaves the status-quo intact and is positive for the European steel firm.
- BW Offshore shares fell as much as 13% after the Norwegian energy company cut its Ebitda forecast for the full year.
- Oxford Nanopore shares climb as much as 5.4%, to its highest in nearly a year, after Panmure Liberum upgraded the stock to buy from hold, saying the British DNA sequencing firm’s new strategy unveiled last week addresses many of its concerns.
See omnystudio.com/listener for privacy information.

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- Alibaba shares fell as much as 10% after the e-commerce giant raised HK$80 billion ($10.2 billion) in Hong Kong’s biggest secondary share sale, underscoring its willingness to amass and spend vast sums to take the lead in global artificial intelligence.
- Samsung shares slid as much as 8% as investors were disappointed by a new shareholder return package that favors dividends.
- Nvidia shares slump after reports that the tech company is in talks to invest in AI startup Perplexity, which follows an announcement that the prices of many servers containing its artificial intelligence chips are going up more than 15%.
See omnystudio.com/listener for privacy information.

Earnings are in focus with Nvidia, Crowdstrike, and Marvell Technology reporting in the coming days.

Bloomberg’s Nathan Hager previews what to expect from these companies in the week ahead with Mandeep Singh, Global Head of Tech Research for Bloomberg Intelligence.




See omnystudio.com/listener for privacy information.

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers, we take a look at some of the biggest gainers and decliners of the week:
- Moderna (MRNA) saw it shares soar to a record 177%, adding around $44 billion in value on Wednesday after it announced a personalized vaccine it developed with Merck (MRK) reduced the recurrence of melanoma in a large, late-stage trial. The breakthrough raises expectations for treating the deadliest form of skin cancer and shows the promise of the embattled mRNA technology.
- Crowdstrike (CRWD) shares fell after Axios reported the company chief technology officer is departing to start an AI-cyber fund. Current CTO Elia Zaitsev's new venture firm is reportedly targeting a $170 million fund.
- Estée Lauder (EL) shares soared after the beauty conglomerate ended a run of three straight declines in annual revenue, reinforcing that turnaround efforts are paying off. The shares closed 16% higher in New York on Wednesday, the biggest daily gain since 2011. The advance pared the stock’s year-do-date decline to 6%.
See omnystudio.com/listener for privacy information.

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
Listen for comprehensive cross-platform coverage of the US market close as heard on Bloomberg Television, Bloomberg Radio, and YouTube with Romaine Bostick, Sally Bakewell, Carol Massar and Tim Stenovec.
- Moderna (MRNA) and Merck (MRK) shares continued to gain on investor enthusiasm over their new personalized cancer vaccine. Earlier in the week, Moderna jumped to its biggest intraday gain on record.
- Boston Beer (SAM) shares dropped in trading on Friday, after the alcoholic beverage maker announced Chief Financial Officer Diego Reynoso will be leaving the company on Sept. 14 to accept a new opportunity. Citi views Reynoso’s exit as a “meaningful loss” to the Samuel Adams maker given his key role in the company’s margin recovery program.
- Ubiquiti (UI) shares fell the most since May after the wireless-network equipment provider posted fiscal fourth-quarter gross margin that shrank from the third quarter. The margin was hurt by higher costs of components and shipping.
See omnystudio.com/listener for privacy information.